scholarly journals A CURIOUS CASE OF RAPIDLY PROGRESSIVE PURULENT EFFUSIVE-CONSTRICTIVE PERICARDITIS WITH CARDIAC TAMPONADE

2021 ◽  
Vol 77 (18) ◽  
pp. 2193
Author(s):  
Marsel Matka ◽  
Michael McLane ◽  
Jose D. Amortegui ◽  
Christopher Cutitta
2018 ◽  
Vol 02 (05) ◽  
Author(s):  
Catalina Sanchez-Alvarez ◽  
Monia Werlang ◽  
Oludamilola Oluleye ◽  
Mohamad H Yamani

2018 ◽  
Vol 20 (3) ◽  
pp. 298-306 ◽  
Author(s):  
William R Miranda ◽  
Darrell B Newman ◽  
Lawrence J Sinak ◽  
Raul E Espinosa ◽  
Nandan S Anavekar ◽  
...  

2012 ◽  
Vol 18 (3) ◽  
pp. 277-287 ◽  
Author(s):  
Faisal F. Syed ◽  
Mpiko Ntsekhe ◽  
Bongani M. Mayosi ◽  
Jae K. Oh

Author(s):  
Allan Klein ◽  
Paul Cremer ◽  
Apostolos Kontzias ◽  
Muhammad Furqan ◽  
Ryan Tubman ◽  
...  

Background Patients with recurrent pericarditis (RP) may develop complications, multiple recurrences, or inadequate treatment response. This study aimed to characterize disease burden and unmet needs in RP. Methods and Results This retrospective US database analysis included newly diagnosed patients with RP with ≥24 months of continuous history following their first pericarditis episode. RP was defined as ≥2 pericarditis episodes ≥28 days apart. Some patients had ≥2 recurrences, while others had a single recurrence with a serious complication, ie, constrictive pericarditis, cardiac tamponade, or a large pericardial effusion with pericardiocentesis/pericardial window. Among these patients with multiple recurrences and/or complications, some had features relating to treatment history, including long‐term corticosteroid use (corticosteroids started within 30 days of flare, continuing ≥90 consecutive days) or inadequate treatment response (pericarditis recurring despite corticosteroids and/or colchicine, or other drugs [excluding NSAIDs] within 30 days of flare, or prior pericardiectomy). Patients (N=2096) had hypertension (60%), cardiomegaly (9%), congestive heart failure (17%), atrial fibrillation (16%), autoimmune diseases (18%), diabetes mellitus (21%), renal disease (20%), anxiety (21%), and depression (14%). Complications included pericardial effusion (50%), cardiac tamponade (9%), and constrictive pericarditis (4%). Pharmacotherapy included colchicine (51%), NSAIDs (40%), and corticosteroids (30%), often in combination. This study estimates 37 000 US patients with RP; incidence was 6.0/100 000/year (95% CI, 5.6‒6.3), and prevalence was 11.2/100 000 (95% CI, 10.6‒11.7). Conclusions Patients with RP may have multiple recurrences and/or complications, often because of inadequate treatment response and persistent underlying disease. Corticosteroid use is frequent despite known side‐effect risks, potentially exacerbated by prevalent comorbidities. Substantial clinical burden and lack of effective treatments underscore the high unmet need.


2018 ◽  
Vol 11 (4) ◽  
pp. NP125-NP128
Author(s):  
Neha Bansal ◽  
Henry L. Walters ◽  
Daisuke Kobayashi

Purulent pericarditis is a rare infectious disease with significant mortality, even in the modern antibiotic era. The presenting signs can often be subtle and patients can deteriorate rapidly with cardiac tamponade. We report a previously healthy 16-month-old female who developed purulent pericarditis associated with paronychia and sepsis caused by methicillin-sensitive Staphylococcus aureus. In addition to antibiotic treatment, she required emergent pericardiocentesis for cardiac tamponade, followed by two surgical interventions including full median sternotomy incision and partial pericardiectomy. At 4-month follow-up, she did well with no evidence of constrictive pericarditis on echocardiogram.


Sign in / Sign up

Export Citation Format

Share Document